Constitutive activation of STAT3 and STAT5 is present in the majority of nasopharyngeal carcinoma and correlates with better prognosis

被引:0
|
作者
J-R Hsiao
Y-T Jin
S-T Tsai
A-L Shiau
C-L Wu
W-C Su
机构
[1] Institute of Clinical Medicine,Department of Otolaryngology
[2] College of Medicine,Department of Pathology
[3] National Cheng Kung University,Department of Microbiology and Immunology
[4] National Cheng Kung University Hospital,Department of Biochemistry
[5] National Cheng Kung University Hospital,Department of Internal Medicine
[6] College of Medicine,undefined
[7] National Cheng Kung University,undefined
[8] College of Medicine,undefined
[9] National Cheng Kung University,undefined
[10] National Cheng Kung University Hospital,undefined
来源
British Journal of Cancer | 2003年 / 89卷
关键词
signal transducers and activators of transcription (STAT); nasopharyngeal carcinoma (NPC); Epstein–Barr virus (EBV);
D O I
暂无
中图分类号
学科分类号
摘要
Constitutively activated signal transducers and activators of transcription (STAT) factors, in particular STAT1, STAT3 and STAT5, have been demonstrated in a variety of human tumours and cancer cell lines. However, data on the expression of these STATs in nasopharyngeal carcinoma (NPC) are limited. In this study, the expression patterns of STAT1, STAT3 and STAT5 were immunohistochemically examined on the archival specimens from 61 patients with NPC. Staining results of each STATs were then correlated with the clinical parameters and prognosis of these patients. The results showed that constitutive activation of STAT3 and STAT5 was detected in the majority, 70.5 and 62.3%, respectively, of the 61 tumour specimens. Furthermore, coexpression of activated STAT3 and STAT5 was found in 54.1% of the specimens. In contrast, constitutive activated STAT1 could only be detected in 8 (13.1%) cases. Surprisingly, following radiotherapy, patients with constitutive STAT5 activation, or activation of both STAT3 and STAT5, had better disease-free survival and overall survival than those without activated STAT5. To our knowledge, this is the first report providing the overall expression patterns and prognostic significance of specific STATs in NPC.
引用
收藏
页码:344 / 349
页数:5
相关论文
共 50 条
  • [31] Activation of STAT3 and STAT5 Signaling in Epithelial Ovarian Cancer Progression: Mechanism and Therapeutic Opportunity
    Wu, Chin-Jui
    Sundararajan, Vignesh
    Sheu, Bor-Ching
    Huang, Ruby Yun-Ju
    Wei, Lin-Hung
    CANCERS, 2020, 12 (01)
  • [32] Increased Stat3 and Stat5 protein expression correlates with aggressive biologic phenotype in prostatic adenocarcinomas (PACs)
    Kallakury, BVS
    Sheehan, GM
    Sheehan, CE
    Fisher, HAG
    Kaufman, RP
    Ross, JS
    LABORATORY INVESTIGATION, 2005, 85 : 149A - 149A
  • [33] Increased Stat3 and Stat5 protein expression correlates with aggressive biologic phenotype in prostatic adenocarcinomas (PACs)
    Kallakury, BVS
    Sheehan, GM
    Sheehan, CE
    Fisher, HAG
    Kaufman, RP
    Ross, JS
    MODERN PATHOLOGY, 2005, 18 : 149A - 149A
  • [34] STAT3 and STAT5 Signaling Thresholds Determine Distinct Regulation for Innate Receptor-Induced Inflammatory Cytokines, and STAT3/STAT5 Disease Variants Modulate These Outcomes
    Hedl, Matija
    Sun, Rui
    Huang, Chen
    Abraham, Clara
    JOURNAL OF IMMUNOLOGY, 2019, 203 (12): : 3325 - 3338
  • [35] STAT3 and STAT5 Targeting for Simultaneous Management of Melanoma and Autoimmune Diseases
    Logotheti, Stella
    Puetzer, Brigitte M.
    CANCERS, 2019, 11 (10)
  • [36] Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers
    Brachet-Botineau, Marie
    Polomski, Marion
    Neubauer, Heidi A.
    Juen, Ludovic
    Hedou, Damien
    Viaud-Massuard, Marie-Claude
    Prie, Gildas
    Gouilleux, Fabrice
    CANCERS, 2020, 12 (01)
  • [37] Constitutive activation of Stat1 and Stat3 in primary erythroleukemia cells
    Kirito, K
    Nagashima, T
    Ozawa, K
    Komatsu, N
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 75 (01) : 51 - 54
  • [38] STAT3,STAT5靶向肿瘤治疗研究进展
    曹兵
    王鸿程
    国际内科学杂志, 2007, (09) : 518 - 520
  • [39] STAT3 and STAT5 regulations in gallic Acid & quercetin treated cells
    Gul, Huseyin
    Zergeroglu, Asuman Demiroglu
    ANTI-CANCER DRUGS, 2015, 26 : E27 - E27
  • [40] The Status of STAT3 and STAT5 in Human Breast Atypical Ductal Hyperplasia
    Shi, Aiping
    Dong, Jie
    Hilsenbeck, Susan
    Bi, Lirong
    Zhang, Hong
    Li, Yi
    PLOS ONE, 2015, 10 (07):